This $2,010,044 federal Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) will assess the impact of Institutional Special Needs Plan (I-SNP) enrollment on quality of long-term and end-of-life care for elderly nursing home residents with Alzheimer's disease and related dementias (ADRD). The study will use a mixed-methods approach, including quasi-experimental econometric analyses on Medicare claims and health record data, as well as...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) for $2,278,636 aims to characterize and evaluate different nursing home clinician care models and their impact on health outcomes and costs for nursing home residents with Alzheimer's disease and related dementias. The primary awardee, the Trustees of the University of Pennsylvania, will survey a nationally representative sample of nursing home clinicians and link their practice...
This Project Grant award of $318,416 from the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866) will fund a research study on the impact of hospice care on the well-being of Alzheimer's disease (AD) patients and their family members.
The project has two key aims: 1) to examine how hospice care affects the cognitive, functional, and physical well-being of AD patients using large Medicare claims and health assessment datasets, and 2) to analyze the...
This $3,732,394 five-year project grant, awarded by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to evaluate the effectiveness of the Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP) intervention in improving dementia care quality outcomes, including increased documentation of advance care planning discussions and rates of hospice admission, at 30 assisted living facilities. The project also seeks to assess the impact of the...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data...
This federal Project Grant award, funded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), is intended to examine ways to align the incentives created by the Medicare and Medicaid programs in nursing homes to improve care for residents with Alzheimer's disease and related dementias (AD/ADRD).
The $2,210,409 award, granted to the Trustees of the University of Pennsylvania (doing business as the Clinical Practices of the University of Pennsylvania), aims...
This $2,374,537 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research project conducted by the University of California, San Francisco (UCSF) to examine how changing values and self-narratives in individuals with different dementia syndromes impact caregiving relationships and burden. The key products or services to be delivered under this 3-year project include:
In-depth qualitative interviews with people who have early Alzheimer's...
The National Institute on Aging (NIA) awarded a $1,623,380 Project Grant under the Aging Research program (CFDA 93.866) to Cedars-Sinai Medical Center to examine the impact of physician, hospital, and skilled-nursing facility factors related to geriatric care on days spent at home among persons with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The study aims to determine how factors such as clinician subspecialty training, patient volume, interdisciplinary care...
This $199,375 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a study conducted by Brown University to examine the quality of hospice care provided to Medicare beneficiaries with Alzheimer's and related dementias (ADRD) in long-term care (LTC) settings. The key objectives are to: 1) describe characteristics associated with receiving care from LTC-focused hospices, and 2) compare quality outcomes between ADRD beneficiaries cared for...
This federal Project Grant award, worth $561,600, was issued by the National Institute on Aging (NIA) under the Aging Research grant program (CFDA 93.866). The award funds a 2-year research project led by Dr. Matthew Growdon at the University of California, San Francisco (UCSF) to characterize medication use and management supports among people with dementia who live alone. The key products and services to be delivered under this grant include:
Evaluating medication use and medication...
This federal Project Grant award of $199,263 from the National Institute on Aging (NIA), under the Aging Research grant program (CFDA 93.866), will support a research study titled "PROJECT GLORY: GOOD LIFE IN MEMORY CARE". The goal of the study is to contribute to the understanding of how to ensure a "good life" for residents with Alzheimer's disease and related dementias (ADRD) living in nursing homes.
The project will involve three main aims: 1) collecting firsthand experiences from residents, families, and staff on quality of life and care practices; 2) integrating these findings into an evidence-informed "good life" model of nursing home care; and 3) implementing and evaluating this model through a small randomized controlled trial. The findings are expected to inform future research and have implications for promoting the quality of life for persons with ADRD in long-term care settings.